It is a chemicals private limited company based in Noida, Uttar Pradesh, India, established in 2018.
2018 | Noida, Uttar Pradesh, India | ActiveAvrido Pharmaceuticals Private Limited, a active private limited company, was established on 30 July 2018 in Noida, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100UP2018PTC106622. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Sp Quick Expo Private Limited. Its leadership includes Shashipal Yadav (Director), Naveen Kumar (Director), Sushil Kumar Singh (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-25, G/F Sector 1, Noida, Uttar Pradesh, 201301.
U24100UP2018PTC106622
106622
30 July 2018
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Avrido Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shashipal Yadav | Director | 30 Jul 2018 | Current |
| Naveen Kumar | Director | 30 Jul 2018 | Current |
| Sushil Kumar Singh | Director | 16 Aug 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avrido Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.74% increase. The company also saw a slight improvement in profitability, with a 1.26% increase in profit. The company's net worth dipped by a decrease of 4.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Avrido Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Avrido Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Avrido Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avrido Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Avrido Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Avrido Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.
Progress on Sushil Kumar Singh was appointed as a Director was appointed as a Director on 16 Aug 2022 & has been associated with this company since 3 years 4 months . was documented.
The activity Shashipal Yadav was appointed as a Director was appointed as a Director on 30 Jul 2018 & has been associated with this company since 7 years 4 months . was completed.
Naveen Kumar was appointed as a Director was appointed as a Director on 30 Jul 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
Progress on Avrido Pharmaceuticals Private Limited was registered on 30 Jul 2018 with Roc Kanpur & aged 7 years 4 months as per MCA records. was documented.
The CIN of Avrido Pharmaceuticals Private Limited is U24100UP2018PTC106622.
Avrido Pharmaceuticals Private Limited is headquartered at B-25, G/F Sector 1, Noida, Uttar Pradesh, 201301.
Avrido Pharmaceuticals Private Limited was incorporated on 30 July 2018.
The current directors of Avrido Pharmaceuticals Private Limited are
The primary industry of Avrido Pharmaceuticals Private Limited is Chemicals.
Avrido Pharmaceuticals Private Limited is unlisted.
The authorized capital of Avrido Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX